On April 29 2026, Rockwell Automation and Cytiva launched the Figurate SCADA system, an open‑architecture platform that provides real‑time oversight across diverse biopharmaceutical equipment. The system is designed to eliminate digital bottlenecks that slow tech transfer and scale‑up, allowing biopharma teams to reduce manual workarounds and improve data integrity.
The launch marks a strategic expansion for Rockwell into the life‑sciences sector, where continuous manufacturing and data‑driven process intensification are becoming industry standards. By partnering with Cytiva, a leader in bioprocessing solutions, Rockwell gains a specialized control layer that aligns with the unique regulatory and operational demands of biopharma.
The Figurate SCADA system’s open‑architecture design enables seamless integration of third‑party equipment across multiple modalities, accelerating tech transfer and reducing the time required to bring new products to market. This capability addresses a key pain point for biopharma companies that must maintain rigorous quality and compliance while scaling production.
The launch comes as Rockwell reported strong Q1 FY2026 results, with earnings per share of $2.75 versus analysts’ estimate of $2.46 and revenue of $2.11 billion versus the $2.08 billion forecast. The company’s focus on high‑margin software and services, AI, digital twins, and IIoT has driven recurring revenue growth and positioned it to capture the expanding SCADA market, which is projected to grow significantly as the pharmaceutical sector adopts real‑time process control.
Matt Weaver, Vice President of Global Industry Life Sciences at Rockwell Automation, said, "Biopharma teams are under pressure to move more quickly, but their systems are often not built to keep up." He added, "This collaboration with Cytiva marks a pivotal step in our mission to democratise digital manufacturing, enabling biopharma innovators to deploy SCADA faster, smarter and more affordably." The partnership underscores Rockwell’s commitment to delivering end‑to‑end digital solutions that meet the stringent quality and regulatory requirements of the life‑sciences industry.
The Figurate SCADA system positions Rockwell to capitalize on the growing demand for digital manufacturing in biopharma, competing with industry leaders such as Siemens, ABB, and Schneider Electric. The launch also aligns with broader trends of digital transformation in life sciences, where real‑time monitoring, data integration, and process optimization are critical to achieving faster time‑to‑market and maintaining regulatory compliance.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.